Atopic Dermatitis | Pfizer | B7451014
Pharmaceutical Company/Sponsor:
Pfizer
Code:
B7451014
Title:
A PHASE 3 RANDOMIZED WITHDRAWAL, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY INVESTIGATING THE EFFICACY AND SAFETY OF PF-04965842 IN SUBJECTS AGED 12 YEARS AND OVER, WITH MODERATE TO SEVERE ATOPIC DERMATITIS WITH THE OPTION OF RESCUE TREATMENT IN FLARING SUBJECTS
Type:
Interventional
Phase:
3
Condition/Disease:
Atopic Dermatitis
Intervention(s)/Treatment(s):
Drug: PF-04965842 100 mg
Drug: PF-04965842 200 mg
Drug: Placebo
Status:
Active, Not Recruiting
Link for Additional Information:
